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Abstract
Recent studies on the large Maf transcription factors have shown that Mafb and Mafa have respective and distinctive roles
in b-cell development and maturation. However, whether this difference in roles is due to the timing of the gene expression
(roughly, expression of Mafb before birth and of Mafa after birth) or to the specific function of each gene is unclear. Our aim
was to examine the functional differences between these genes that are closely related to b cells by using an in vivo model
of b-like cell generation. We monitored insulin gene transcription by measuring bioluminescence emitted from the liver of
insulin promoter-luciferase transgenic (MIP-Luc-VU) mice. Adenoviral gene transfers of Pdx1/Neurod/Mafa (PDA) and Pdx1/
Neurod/Mafb (PDB) combinations generated intense luminescence from the liver that lasted for more than 1 week and
peaked at 3 days after transduction. The peak signal intensities of PDA and PDB were comparable. However, PDA but not
PDB transfer resulted in significant bioluminescence on day 10, suggesting that Mafa has a more sustainable role in insulin
gene activation than does Mafb. Both PDA and PDB transfers ameliorated the glucose levels in a streptozotocin (STZ)-
induced diabetic model for up to 21 days and 7 days, respectively. Furthermore, PDA transfer induced several gene
expressions necessary for glucose sensing and insulin secretion in the liver on day 9. However, a glucose tolerance test and
liver perfusion experiment did not show glucose-stimulated insulin secretion from intrahepatic b-like cells. These results
demonstrate that bioluminescence imaging in MIP-Luc-VU mice provides a noninvasive means of detecting b-like cells in
the liver. They also show that Mafa has a markedly intense and sustained role in b-like cell production in comparison with
Mafb.
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Introduction
The development of pancreatic b cells is a highly orchestrated
process that involves many extracellular stimulants and intracel-
lular signaling pathways. At embryonic day 9.5 (E9.5), the
pancreas evolves from the dorsal and ventral buds of the foregut’s
endodermal epithelium [1]. After gut rotation and fusion of the
dorsal and ventral rudiments at around E11.5, the pancreatic
epithelium initiates branching by sending finger-like epithelial
protrusions into the surrounding mesenchyme [2]. As a branching
duct-like structure forms, endocrine progenitors expressing
neurogenin 3 within the trunks delaminate from the developing
epithelium. Subsequently, progenitor cells successively differenti-
ate into each hormone-producing cell under the hierarchical
control of a lineage-specific molecular cascade [2]. Among the 5
different types of endocrine cells in the Langerhans islets, the
development of b cells has been the most intensively investigated
in relation to future complementation therapy against diabetes.
The Maf family of transcription factors, which is a member
of the basic leucine-zipper (bZip) transcription factor family, are
homologs of v-Maf, the oncogenic component of the avian
retrovirus AS42 originally identified in the genome of chicken
musculoaponeurotic fibrosarcoma (MAF), and are subdivided
into 2 groups, small and large MAF proteins, according to their
structure, function, and molecular size [3–5]. Three small MAF
proteins, MAFF, MAFG, and MAFK, lack a transactivation
domain and regulate genes important in hematopoiesis and the
stress response by forming a heterodimer with other bZIP
factors such as cap’n’collar (CNC) family proteins. To date,
abnormalities in pancreatic development and glucose homeo-
stasis of small maf knockout mice have not been reported [6].
In contrast, the large MAF proteins comprise 4 distinct proteins,
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MAFA, MAFB, c-MAF, and NRL, which are characterized by
the presence of an N-terminal transactivation domain. In b-cell
development, at E15.5, 50%, and 90% of insulin-positive cells
express Mafa and Mafb, respectively; however, in adult mice,
Mafa and Mafb are preferentially expressed in b cells and a
cells, respectively [7]. Therefore, this switch from Mafb to Mafa
expression in b cells probably has a crucial meaning for
functional maturation in both mouse models and in human
embryonic stem cell differentiation [7,8].
Bioluminescence imaging (BLI) in small animals is a versatile
and cost-effective technology that has high sensitivity and
efficiency [9]. In b-cell research, BLI has been employed for the
quantification of b-cell mass, monitoring of islet graft survival after
transplantation, and detection of reporter gene expression [10–
12]. Recently, we have shown that BLI of luciferase reporter mice,
which can express luciferase under the control of the Ins1 gene,
could also be useful for the detection of fetal b-cell genesis in utero
and for intrahepatic insulin gene activity [13,14].
In this study, we aimed to examine the functional differences
between Mafa and Mafb using an in vivo model of b-like cell
conversion. Although these closely related genes each have their
distinctive role in b-cell development (Mafb) and maturation
(Mafa), whether the difference is due to the timing of the gene
expression or to the characteristic features of each gene is
unclear. Even though both Mafa and Mafb similarly activate
insulin gene expression through the Maf recognition element
(MARE) in vitro, the less-conserved N-terminal activation
domain of the large Maf transcription factors raises the
possibility of different activation potentials and/or downstream
targets [7]. Here, we transduced b cell-related genes, including
Mafa and Mafb, into the livers of insulin reporter mice and
compared the transcriptional activities of insulin and glucose
metabolism. Gene transfer including of Mafb could activate the
insulin gene in the mouse liver. However, a combination gene
transfer including Mafa demonstrated more efficient and
sustainable insulin induction for most experiments when
compared with Mafb. These findings provide insight into the
reprogramming cell potency of the Mafa gene and the gene-
specific functions of Mafa and Mafb in normal b-cell
generation.
Materials and Methods
Animals
All experiments were performed in compliance with the relevant
Japanese and institutional laws and guidelines and approved by
the University of Tsukuba animal ethics committee (authorization
number 13–072). Transgenic mice expressing luciferase under the
control of the mouse ins1 promoter [FVB/N-Tg(Ins1-luc)-
VUPwrs/J; Stock number: 007800; MIP-Luc-VU] were pur-
chased from the Jackson Laboratory (Bar Harbor, ME, USA).
Jcl:ICR mice purchased from Clea (Clea Japan, Tokyo, Japan)
were mated for the experiments. Mice were euthanized at the
appropriate time points with carbon dioxide gas.
Preparation of recombinant adenovirus vectors
Recombinant adenoviruses expressing mouse Pdx1, Neurod
(kindly gifted by Dr. S. Yoshida), Mafa, and Mafb were prepared
using the ViraPower Adenoviral Gateway Expression kit (Life
Technologies, Carlsbad, CA, USA). Each cDNA fragment was
cloned into a pENTR4 entry vector. To create expression clones
and produce recombinant adenoviruses, the pENTR4 inserts were
transferred into pAd/CMV/V5-DEST destination vectors using
the LR recombination reaction, and PacI-linearized plasmids were
transfected into 293A cells (Life Technologies) by using Fugene 6
transfection reagent (Roche Diagnostics, Basel, Switzerland). The
viruses were propagated in 293A cells and purified using CsCl2
banding followed by dialysis against 10 mM Tris-HCl, pH 8.0
with 2 mM MgCl. The infectious titers were determined using the
Adeno-X Rapid Titer kit (Takara, Shiga, Japan). The successful
adenoviral gene transfer is shown in Figure S1A, in which 56109
infectious units of the viruses were injected into wild-type mice,
and immunohistochemistry using the target antibodies was
performed 3 days after the infection. 39.663.9%, 26.465.8%,
46.563.2%, 57.365.8%, of liver cells reacted to PDX1,
NEUROD, MAFA, and MAFB antibodies, respectively (n = 3)
(Figure S1A).
Bioluminescence imaging
Adenoviral constructs (56109 IFU) expressing GFP (Ad-GFP),
PDX1, NEUROD, and MAFA (Ad-PDA) and PDX1, NEU-
ROD, and MAFB (Ad-PDB) were intravenously injected into
the MIP-Luc-VU mice. Serial BLI was performed before and
after infection on the designated days. The day of injection was
determined as day 0. To detect the bioluminescence signals
emitted from the free-fed mice, D-luciferin (5 mg/kg body
weight; Promega, Madison, WI, USA) was injected intraperito-
neally, and bioluminescence images were taken using an IVIS
spectrum 5 minutes later (Caliper Life Sciences, Hopkinton,
MA, USA). Bioluminescence images were captured with an
integration time of 1 minute, and isometric regions of interest
(ROIs) were drawn over the location corresponding to the liver
for the quantification using Living Image software (Xenogen
Corporation, Alameda, CA, USA).
Quantitative RT-PCR
Total RNA was extracted from the liver using the NucleoSpin
RNA II kit (Machery-Nagel, Du¨ren, Germany), and 1 mg was used
to prepare cDNA primed with random hexamers and reverse-
transcribed with the QuantiTect Reverse Transcription kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. Gene expression levels were compared by real-time
RT-PCR using the Thermal Cycler Dice Real Time system
(Takara) with a SYBR Green PCR master mix (Takara). Values
were normalized to expression levels of Hprt and shown in relative
amount to the PDA group at day 3. All primer sequences are listed
in Table 1 [15].
Measurement of insulin content
Hepatic insulin after adenovirus infection was extracted by the
acid-ethanol method as described previously, and the content
measured with an insulin enzyme-linked immunosorbent assay kit
(Morinaga Bioscience, Yokohama, Japan) [16]. The insulin
content was normalized to the total protein concentration
measured by a Coomassie protein assay reagent (Thermo
Scientific, Hudson, NH, USA).
Diabetes induction
Wild-type mice were rendered diabetic at 6 weeks of age by IP
injection of streptozotocin (STZ, Sigma) at a dose of 200 mg/kg
body weight in 0.1 M citrate buffer (pH 4.5). The serum glucose
concentrations of the mice after they had been subjected to a 12-
hour overnight fast were measured using a Dry-chem 3500
automated analyzer for routine laboratory tests (Fujifilm, Tokyo,
Japan). The serum insulin levels were measured with an
ultrasensitive insulin enzyme-linked immunosorbent assay kit
(Morinaga).
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Immunostaining
The MIP-Luc-VU mice were euthanized at 8 weeks of age, and
the livers removed. Tissues were fixed in 10% formalin and
embedded in paraffin. The tissue sections were incubated with
anti-insulin antibody (Abcam, Cambridge, UK) for 8 hours at
4uC. The antigens were visualized using appropriate secondary
antibody conjugated with Alexa 596 with nuclear staining using
49,6-diamidino-2-phenylindole (DAPI) (Invitrogen). Images of the
sections were scanned and analyzed using a Biorevo BZ-9000
microscope (Keyence, Osaka, Japan) and BZ-II Analyzer software
(Keyence).
In situ liver perfusion
The experiment was performed according to a previous
report by Yechoor et al [17]. Briefly, anesthetized mice were
cannulated via the portal vein for infusion and via the inferior
vena cava (IVC) through the right atrium for collection of the
effusate. After the initial washout, a peristaltic pump was used
to perfuse the isolated liver with KRB buffer (119 mM NaCl,
4.7 mM KCl, 25 mM NaHCO3, 2.5 mM CaCl2, 1.2 mM
MgSO4, 1.2 mM KH2PO4, and 0.25% BSA) containing
different concentrations of glucose. Finally, after another
washout, glibenclamide (10 nM; Sigma) and KCl (25 mM) were
added. The insulin concentration of the effusate was measured
10 minutes after each perfusion of glucose.
Statistical analysis
Data were expressed as the means 6 standard errors of the
means and compared using an unpaired t test, unless otherwise
stated. Probability values of less than 0.05 were considered
significant.
Results
To screen the transcriptional activity of the intrahepatic insulin
gene in a noninvasive manner, we monitored the bioluminescence
emissions from MIP-Luc-VU mice after adenovirus-mediated
gene transfer (Figure 1A). We transferred a 3-gene combination of
Pdx1, Neurod, and Mafa into the MIP-Luc-VU mice with
different infectious titers to detect the bioluminescence signal
3 days after infection, according to a previous study (Figure 1B)
[18]. After luciferin injection (5 mg/kg body weight, IP) into the
gene-transferred mouse, within minutes the emission from the liver
rose quickly and then gradually attenuated (Figure S1B). The 3-
gene transfer resulted in a dose-dependent bioluminescence
emission in the hepatic region, which was identified as originating
from the liver by imaging of the extracted tissues and by
immunohistochemistry using anti-luciferase antibody (Figure 1B,
C, D). Most hepatic cells exhibit reporter expression, whereas
immunohistochemistry using anti-insulin antibody showed very
few luciferase-positive cells expressing insulin protein, indicating
the existence of some regulatory mechanisms of the transcription
and the protein levels of insulin, such as mRNA and protein
degradation and leakage of produced insulin into the blood
circulation (Figure S1C).
To compare the effects of Mafa and Mafb on the
transcriptional activity of the insulin gene through measurement
of the bioluminescence emission, we examined 3 different gene
combinations – Pdx1/Neurod (PD); Pdx1, Neurod, and Mafa
(PDA); and Pdx1, Neurod, and Mafb (PDB) – in MIP-Luc-VU
mice (Figure 2A). The bioluminescence signals induced by the 3
different combinations peaked at day 3 and gradually disap-
peared over 14 days in the same way. The PDA
(1.8160.346109/photons/sec/cm2/steradian; n = 7) and PDB
(1.7060.336109/photons/sec/cm2/steradian; n = 8) transduc-
tions induced comparable but significantly higher signal
intensities than the peak emission of PD (4.4962.66107/
photons/sec/cm2/steradian; n = 4) at day 3 (Figure 2B). In
contrast, only the PDA-transferred mice continued to emit
substantial bioluminescence, even at day 10, suggesting that
Mafa is capable of inducing a peak emission similar to but a
more sustainable insulin gene activity than that of Mafb (PD:
1.2860.16105/photons/sec/cm2/steradian; n = 4, PDA:
2.4660.86107/photons/sec/cm2/steradian; n = 7, PDB:
1.9660.46105/photons/sec/cm2/steradian; n= 8) (Figure 2C).
Furthermore, immunohistochemistry using anti-insulin antibody
revealed that some PDA- and PDB-transferred liver cells reacted
to the antibody at days 3 and 9 after infection (Figure 2D). To
confirm the presence of insulin-positive cells in PDB-transferred
liver, DAB (3, 39-diaminobenzidine) visualization is also shown
in Figure S2A. We next examined the insulin content of the
gene-transferred livers at days 3 and 9 after infection (Figure 3).
Consistent with the bioluminescence results, we found no
difference among the groups at day 3 (GFP: 0.3160.2 ng/mg;
n = 4; PDA: 1.2660.5 ng/mg; n= 7; PDB: 2.660.3 ng/mg;
n = 5), but the PDA-transferred liver at day 9 (6.2361.3 ng/mg,
n = 4) contained fairly abundant amounts of insulin protein
when compared with the other groups. Interestingly, the insulin
content of the PDA-transferred liver at day 9 was increased 5-
fold over that of day 3, suggesting that newly synthesized insulin
protein is gradually stored in the liver.
Table 1. Primer sequences used in the study.
Gene symbol Forward primer sequences Reverse primer sequences
Ins1 59-CCAGCTATAATCAGAGACCA-39 59-GGGCCTTAGTTGCAGTAGTT-39
Ins2 59-AGGAAGCCTATCTTCCAGGT-39 59-ATTCATTGCAGAGGGGTAGG-39
Slc2a2 59-TGGGATGAAGAGGAGACTGAA-39 59-CATCCGTGAAGAGCTGGATCA-39
Pcsk2 59-AATGACCCCTAACCCATACCC-39 59-GAGGAGGGTTCGATGATGTC-39
islet Gck 59-TGGATGACAGAGCCAGGATGG-39 59-ACTTCTGAGCCTTCTGGGGTG-39
Sur1 59-CTGGTCCTCAGCAGCACAT-39 59-GGAACTCTTGGGACGAGACA-39
Kcnj11 (Kir6.2) 59-GTAGGGGACCTCGGAAAGAG-39 59-TGGAGTCGATGACGTGGTAG-39
Sytl4 59-CCAGCACACAAAGGCGAGT-39 59-GAAGGAGGTATCCCTTGACAAAG-39
Hprt 59-GGCTTCCTCCTCAGACCGCTTT-39 59-AGGCTTTGTATTTGGCTTTTCC-39
doi:10.1371/journal.pone.0113022.t001
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To examine the gene expression profiles related to b-cell
function, we performed quantitative RT-PCR analysis using
RNAs recovered from whole liver cells (GFP, n= 6) (Figure 4).
The expressions of Pdx1, Neurod, Mafa, and Mafb are shown in
Figure S2B. Both Ad-PDA (n= 7) and Ad-PDB (n = 7) treatment
induced comparable expression levels of b cell-related genes,
including Slc2a2 and Pcsk2, 3 days after infection, but only in the
PDA-transfer group were the expressions sustained for longer than
1 week. In contrast to this significant b cell-related gene induction,
immunohistochemistry showed that other hormones including
glucagon, pancreatic polypeptide (PP), and somatostatin were not
induced by the Ad-PDA and Ad-PDB treatments (data not shown).
Furthermore, other b cell-specific transcription factors, such as
Nkx2.2, Nkx6.2, and Pax4 that are detected in normal b-cell
development, were neither induced nor increased by PDA-gene
transfer, suggesting that transient b-like cell induction does not
occur in the similar molecular cascade to that of the regular
developmental process of b cells.
Next, to examine whether hepatic insulin production induced
by PDA can ameliorate blood glucose levels in the diabetic
model, we injected 200 mg/kg STZ into ICR mice, followed by
control Ad-GFP (n= 8) or Ad-PDA (n= 5) treatment on day 7
after diabetes induction. As shown in Figure 5A, fasting blood
glucose levels were recovered by Ad-PDA treatment for up to
21 days, which was more pronounced and persistent than the
effects of Ad-PDB treatment (n = 7) (Figure 5A). Consistent with
this result, serum insulin levels after 12 hours of fasting in the
mice treated with Ad-PDA (3.8761.2 ng/ml, n = 4) were
significantly higher than those in the mice treated with Ad-
GFP (0.08860.02 ng/ml, n = 5) or Ad-PDB (0.1860.07 ng/ml,
n = 4) (Figure 5B). Furthermore, we also performed an intra-
peritoneal glucose tolerance test 7 and 14 days after the
adenovirus injection. As shown in Figure 5C (7 days) and 5D
(14 days), the Ad-PDA-treated mice showed lower glucose levels
at each time point after the glucose stimulation; however, the
reduction in blood glucose levels in the Ad-PDA-treated mice
(n = 4) was very consistent at all time points – about 150 mg/dL
(day 7) and 50 mg/dL (day 14) – when compared with those in
the Ad-GFP-treated mice (n = 6). These results raise the
possibility that Ad-PDA treatment could not give rise to mature
insulin-producing cells capable of secreting insulin in response to
glucose levels despite the significant improvement in fasting
blood glucose levels in the STZ diabetic model.
Finally, to examine directly whether PDA-transferred liver cells
are capable of secreting insulin in respond to glucose stimulation,
we performed an in situ liver perfusion experiment (Figure 6A, B).
Figure 1. Bioluminescence emission from the hepatic region of MIP-Luc-VU mice after b cell-related gene transfer. (A) Diagrammatic
representation of bioluminescence monitoring of insulin transcriptional activity. (B) Representative example of dose-dependent bioluminescence
emission from the hepatic region. (C) Bioluminescence images of the abdominal section of MIP-Luc-VU mice 3 days after infection. (D) Tissue sections
of MIP-Luc-VU liver stained with anti-luciferase antibody with 49,6-diamidino-2-phenylindole (DAPI) 3 days after gene transfer. Scale bar indicates
100 mm.
doi:10.1371/journal.pone.0113022.g001
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Solutions containing different glucose concentrations were infused
via the portal vein, and the liver effusion was collected for the
measurement of insulin and glucose concentrations. In contrast to
the Ad-GFP treatment, the Ad-PDA and Ad-PDB treatments led
to high insulin secretion at all time points; however, stepwise
increase in insulin secretion did not occur during glucose
stimulation in the infusate from 2.8 to 11.1 and 25 mM.
Consistent with the result of the intraperitoneal glucose tolerance
test, this result indicates that liver cells after PDA-gene transfer
secrete insulin independent of glucose concentration, similar to
basal insulin secretion.
Discussion
In this study, we used b-like cell induction in the mouse liver to
examine the functional differences between 2 large Maf transcrip-
tion factor genes that are expressed in the pancreatic islets.
Although no reports have been published on the successful
generation of b-like cells by overexpression of gene combination
including Mafb by other types of cells, we transiently but
successfully induced insulin-producing cells by overexpression of
Mafb in combination with Pdx1 and Neurod [19]. However,
hepatic insulin-producing cells induced by Ad-PDB treatment
demonstrated defective expressions of Pcsk2 and islet Gck
(Figure 4) and insulin release in a glucose-independent manner
(Figures 5, 6), suggesting that Mafb is capable of stimulating b-cell
conversion to the immature and transitional states [20]. Mean-
while, the possibility remained that PDB and PDA transfer
induced a few mature b cells, the phenotype of which is masked by
the majority of immature b cells. Notably, MAFB+ insulin+ cells
are generated during the normal b-cell differentiation process
before the emergence of MAFA+ insulin+ cells, implying that the
transition from Mafb to Mafa is critical to b-cell maturation [5,7].
Meanwhile, b cells acquire the capability of glucose-stimulated
insulin secretion during postnatal days 0 to 10, when downregu-
lation ofMafb expression takes place in b cells [21,22]. Therefore,
alteration of gene expression profiles after birth might also be
Figure 2. Comparison of the transcription of insulin in the liver by use of bioluminescence imaging. (A) Representative bioluminescence
imaging of MIP-Luc-VU mice after Pdx1/Neurod (PD), Pdx1/Neurod/Mafa (PDA), and Pdx1/Neurod/Mafb (PDB) gene transfer. (B, C) Quantification of
signal intensity after PD (n = 6), PDA (n = 7), and PDB (n = 7) gene transfer at days 3 (B) and 10 (C). (D) Tissue sections of wild-type mouse liver stained
with anti-insulin antibody (red) and 496-diamidino-2-phenylindole (DAPI) (blue) after GFP-, PDA-, and PDB-gene transfer. Arrowheads indicate insulin-
positive cells. Scale bars indicate 100 mm.
doi:10.1371/journal.pone.0113022.g002
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considered for deeper understanding of the molecular mechanism
of b-cell maturation [23].
Large Maf transcription family proteins show relatively high
levels of amino acid similarity in each domain. In mice, MAFB
shares 57%, 86%, and 72% amino acid sequence identities with
the individual acidic, basic, and leucine zipper moieties of
MAFA, respectively [24]. Although we have not determined
which amino acids or regions in MAFA are dominant for the
generation of b-like cells from liver cells, the C-terminal DNA-
binding region of MAFA has been shown to be critical for
insulin induction [19]. In addition, the difference in activity
between MAFA and MAFB might also be related to posttrans-
lational modifications, including phosphorylation, ubiquitination,
and sumoylation [25–30]. Recent studies using gene knockout
mice revealed that Mafa and Mafb regulate different genes
critical for glucose-stimulated insulin secretion and b-cell
development, respectively, supporting our results indicating the
different conversion capabilities of these 2 genes [31].
We demonstrated that bioluminescence monitoring using an
apparatus equipped with a sensitive CCD camera capable of
detecting slight bioluminescence from reporter mice could be
useful for noninvasive monitoring of intrahepatic insulin gene
activity in vivo. Indeed, it has been demonstrated that hepatocytes
or hepatocyte precursors could be converted to insulin-producing
cells using different gene combinations [17,18,32–34]. However, a
comprehensive method for comparing these protocols and
determining the optimal conditions for b-cell generation has not
been established [14]. Our simple and repetitive monitoring
described here provides readily quantifiable data to examine the
efficiency of b-cell induction under different protocols.
In this study, we transduced the same PDA gene combination as
that of a previous report by Kaneto et al [18]. In contrast to ours,
their results demonstrated fairly good insulin secretion in response
to glucose stimulation. This discrepancy is probably due to the
different mouse strains and PDX1 used. They injected adenovirus
expressing a constitutively active form of PDX1, PDX1-VP16
fusion protein, into C57BL/6 mice, whereas we used wild-type
PDX1 and ICR mice. Especially, the PDX1-VP16 form, of which
VP16 is the activation domain from the herpes simplex virus, has
been demonstrated to show potent transdifferentiation activity
when compared with wild-type PDX1 [35,36].
Figure 3. Insulin content in mouse liver after b-like cell-related
gene transfer. Insulin content of wild-type mouse liver at days 3 and 9
after GFP (n = 7), Pdx1/Neurod/Mafa (PDA, n = 8), and Pdx1/Neurod/Mafb
(PDB, n = 5) gene transfer. Data were expressed as the means 6
standard errors of the means and analyzed by one-way ANOVA
followed by the Tukey-Kramer honestly significant difference (HSD) test.
doi:10.1371/journal.pone.0113022.g003
Figure 4. Expression of b cell-related genes in mouse liver after Pdx1/Neurod in combination with Mafa (PDA) or Mafb (PDB) gene
transfer. Wild-type mouse liver treated with Ad-PDA (PDA, n = 7) displayed a significant increase in b cell-related mRNAs at day 9 (Ins1, Ins2, PC2, i-
GK, Sur1, Kir6.2) on Q-PCR analysis. In contrast, the Ad-PDB treated group of mice (PDB, n = 7) displayed a significant increase in Ins1, Ins2, Sur1, and
Kir6.2 only at day 3. Data were normalized to Hprt mRNA abundance and shown as relative expression levels to that of the Ad-PDA-treated group at
day 3. Data were expressed as the means 6 standard errors of the means and analyzed using the Steel-Dwass multiple comparison test.
doi:10.1371/journal.pone.0113022.g004
Dominant Role of Mafa in b-Like Cell Conversion
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Figure 5. Pdx1, Neurod, and Mafa gene transfer in the liver significantly improved blood glucose levels in a streptozotocin-induced
diabetic model in comparison with Pdx1, Neurod, andMafb gene transfer. (A) ICR mice were rendered diabetic by intraperitoneal injection of
streptozotocin (STZ; 200 mg/kg) followed by treatment with Ad-GFP, Ad-PDA, or Ad-PDB (2.56109 IFU). Fasting blood glucose levels were measured
0 to 28 days after the treatment. Data were expressed as the means 6 standard errors of the means and analyzed using the Steel-Dwass multiple
comparison test. (B) Plasma insulin levels in the fasting state 6 days after the treatment. Data were expressed as the means 6 standard errors of the
means, and P values calculated using the Tukey-Kramer honestly significant difference (HSD) test. (C–D) Intraperitoneal glucose tolerance tests 7 (C)
and 14 (D) days after the treatment. After an overnight fast, the STZ-induced diabetic mice were injected intraperitoneally with 2.0 g/kg body weight
of glucose. Blood samples collected at the designated times after glucose challenge were used to measure blood glucose levels. Data were expressed
as the means 6 standard errors of the means, and P values calculated using the Tukey-Kramer HSD test. *P,0.05.
doi:10.1371/journal.pone.0113022.g005
Figure 6. Glucose-independent insulin release from the mouse liver after b-like cell-related gene transfer. (A–B) Glucose-stimulated
insulin release from the livers of Ad-GFP- (n = 6), Ad-PDA- (n = 6), and Ad-PDB- (n = 7) treated mice 7 days (A) and 14 days (B) after treatment by in situ
liver perfusion. Data were expressed as the means 6 standard errors of the means, and P values calculated using the Tukey-Kramer honestly
significant difference (HSD) test. *P,0.05. N.D. indicates no data.
doi:10.1371/journal.pone.0113022.g006
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In summary, we have demonstrated that bioluminescence
imaging in MIP-Luc-VU mice provides a noninvasive means of
monitoring insulin transcriptional activity and the presence of b-
like cells in the liver, and Mafa has a markedly sustainable role in
b-like cell induction in comparison with Mafb.
Supporting Information
Figure S1 (A) Immunohistochemistry of wild-type mouse liver
infected with the indicated viruses 3 days after induction. Liver
tissues were fixed in 4% paraformaldehyde overnight and
embedded in OCT compound (Sakura, Tokyo, Japan). The tissue
sections were incubated with anti-PDX1 (Abcam, ab47267),
NEUROD (Santa Cruz, sc-1084), MAFA (Bethyl, BL1069) and
MAFB (Bethyl, IHC-00351) antibodies and visualized using
appropriate secondary antibodies conjugated with Alexa 596 with
nuclear staining using 49,6-diamidino-2-phenylindole (DAPI)
(Invitrogen). Lower panels indicate negative control sections.
Scale bars indicate 50 mm. (B) Bioluminescence emission from the
liver of PDA-transferred MIP-Luc-VU mice following intraperi-
toneal injection of luciferin. (C) Tissue sections of MIP-Luc-VU
liver stained with anti-luciferase (Promega, G475A) and anti-
insulin (Abcam, ab7842) antibodies with 49,6-diamidino-2-pheny-
lindole (DAPI) 3 days after PDA gene transfer. Scale bar indicates
100 mm.
(TIF)
Figure S2 (A) Immunohistochemistry for anti-insulin antibody
in the livers treated with Ad-GFP (Left), Ad-PDB (Center) and
islets treated with Ad-PDB (Right). Scale bars indicate 50 mm. (B)
Expression of genes delivered in mouse liver treated with Ad-GFP,
Ad-PDA, and Ad-PDB. Primer sequences: 59-TTCCCGAATG-
GAACCGAGC-39 and 59-GTAGGCAGTACGGGTCCTCT-39
for Pdx1; 59-ACAGACGCTCTGCAAAGGTTT-39 and 59-
GGACTGGTAGGAGTAGGGATG-39 for Neurod; 59-
CACTGGCCATCGAGTAGTCA-39 and 59-CTTCACCTC-
GAACTTCATCAGGTC-39 for Mafa; 59-TGAGCATGGGG-
CAAGAGCTG-39 and 59-CCATCCAGTACAGGTCCTCG-39
for Mafb; and 59-GCTATGTGAGCACTCCACAG-39 and 59-
CCATCCAGTACAGGTCCTCG-39 for exogenous specific
Mafb.
(TIF)
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